Factors Affecting Health Related Quality Of Life (HRQoL) In Coronary Heart Disease Without Terminal Disease

Authors

  • Lubna Farhana Medical Faculty Lampung University
  • Dwi Aulia Ramdini Universitas Lampung
  • Rani Himayani Universitas Lampung
  • Mirza Junando Universitas Lampung

DOI:

https://doi.org/10.53089/medula.v14i4.1045

Keywords:

Coronary heart disease, HRQoL, Ischemic Heart Disease

Abstract

Coronary heart disease (CHD) is a disorder in heart function caused by narrowing of the coronary arteries and atherosclerotic plaque, leading to inadequate oxygen supply to the myocardial muscle. According to the World Health Organization (WHO) data from 2012, CHD is the number 1 cause of death with a percentage of 38.3% of total deaths. Patients with CHD commonly experience symptoms such as chest pain and shortness of breath, which significantly impact in their health-related quality of life (HRQoL). Additionally, complex treatment can also have a broad impact on HRQoL. The aim of this article is to identify the factors influencing HRQoL in CHD patients. In this study, a literature review method was employed, utilizing online databases such as Elsevier, PubMed, Springer. Factors such as social support, comorbidities, lifestyle, disease condition, self-management, and sociodemographic factors are known to influence HRQoL in CHD patients.

References

PERKI. Pedoman Tatalaksana Sindrom Koroner Akut. 2018.

AHA. Cardiovascular disease : A costly burden for america projections through. Washington DC: The american heart associatioin office of federal advocacy. 2017.

Severino P, D’amato A, Pucci M, Infusino F, Adamo F, Birtolo L, dkk. Ischemic heart disease pathophysiology paradigms overview: From plaque activation to microvascular dysfunction. International Journal of Molecular Sciences. 2020;21;1–30.

Khan M, Hashim M, Mustafa H, Baniyas M, Al Suwaidi S, Alkatheeri, dkk. Global epidemiology of ischemic heart disease: Results from the global burden of disease study. Cureus. 2020

WHO. World health statistics. World Health Organization. 2012.

Mahmuda L, Nurkusumasari N, Nofaldi F, Astuti P, Syafitri F, Dessy. N. Coronary heart disease: diagnosis and therapy. Solo Journal of Anesthesi, Pain and Critical Care (SOJA). 2021;1;67.

Srivastava S, Shekhar S, Singhbhatia M, Dwivedi S. Quality of life in patients with coronary artery disease and panic disorder: A comparative study. Oman Med J. 2017;32;20–26.

Cordeiro F, Griebeler O, Zeppini G, Pellegrini F, Timm O. Definitions for “palliative care”, “end-of-life” and “terminally ill” in oncology: a scoping review. Enfermería: Cuidados Humanizados. 2020; 9;205–228.

Huang M, Wang R, Wang H. Effect of life review on quality of life in terminal patients: A systematic review and meta-analysis. 2019.

Thomas D. Clinical pharmacy education, practice and research : Clinical pharmacy, drug information, pharmacovigilance, pharmacoeconomics and clinical research. United states: Elsevier. 2019.

Baladón L, Rubio-Valera M, Serrano-Blanco A, Palao D, Fernández A. Gender differences in the impact of mental disorders and chronic physical conditions on health-related quality of life among non-demented primary care elderly patients. Quality of Life Research. 2016; 25;1461–1474.

PERKI. Pedoman Tatalaksana Sindrom Koroner Akut. 2018.

AHA. Cardiovascular disease : A costly burden for america projections through. Washington DC: The american heart associatioin office of federal advocacy. 2017.

Severino P, D’amato A, Pucci M, Infusino F, Adamo F, Birtolo L, dkk. Ischemic heart disease pathophysiology paradigms overview: From plaque activation to microvascular dysfunction. International Journal of Molecular Sciences. 2020;21;1–30.

Khan M, Hashim M, Mustafa H, Baniyas M, Al Suwaidi S, Alkatheeri, dkk. Global epidemiology of ischemic heart disease: Results from the global burden of disease study. Cureus. 2020

WHO. World health statistics. World Health Organization. 2012.

Mahmuda L, Nurkusumasari N, Nofaldi F, Astuti P, Syafitri F, Dessy. N. Coronary heart disease: diagnosis and therapy. Solo Journal of Anesthesi, Pain and Critical Care (SOJA). 2021;1;67.

Srivastava S, Shekhar S, Singhbhatia M, Dwivedi S. Quality of life in patients with coronary artery disease and panic disorder: A comparative study. Oman Med J. 2017;32;20–26.

Cordeiro F, Griebeler O, Zeppini G, Pellegrini F, Timm O. Definitions for “palliative care”, “end-of-life” and “terminally ill” in oncology: a scoping review. Enfermería: Cuidados Humanizados. 2020; 9;205–228.

Huang M, Wang R, Wang H. Effect of life review on quality of life in terminal patients: A systematic review and meta-analysis. 2019.

Thomas D. Clinical pharmacy education, practice and research : Clinical pharmacy, drug information, pharmacovigilance, pharmacoeconomics and clinical research. United states: Elsevier. 2019.

Baladón L, Rubio-Valera M, Serrano-Blanco A, Palao D, Fernández A. Gender differences in the impact of mental disorders and chronic physical conditions on health-related quality of life among non-demented primary care elderly patients. Quality of Life Research. 2016; 25;1461–1474.

Tchicaya A, Lorentz N, Demarest S, Beissel J, Wagner D. Relationship between self-reported weight change, educational status, and health-related quality of life in patients with diabetes in Luxembourg. Health Qual Life Outcomes. 2015;13.

Höfer S, Benzer W, Oldridge N. Change in health-related quality of life in patients with coronary artery disease predicts 4-year mortality. Int J Cardiol. 2014;174;7–12.

Mahirah D, Sauter C, Thach T, Dunleavy G, Nazeha N, Christopoulos G, dkk. Factors associated with health-related quality of life in a working population in singapore. Epidemiol Health. 2021;42.

Azeez A, Al-Abedi G. Quality of life among ischemic heart diseases patients in misan center for the cardiac diseases and surgery in al-amara city. Bahrain Medical Bulletin. 2021; 43.

Cai T, Verze P, Bjerklund J. The quality of life definition: Where are we going? Uro. 2021;1;14–22.

Rascati K. Essentials of pharmacoeconomics. Philadelphia:Wolters Kluwers. 2014.

Lee E, Cha S, Kim G. Factors affecting health-related quality of life in multimorbidity. Switzerland: Healthcare. 9;2021.

Zhang H, Wang Y, Cai X, Tang N, Wei S, Yang Y. Family functioning and health-related quality of life of inpatients with coronary heart disease: a cross-sectional study in Lanzhou city, China. BMC Cardiovasc Disord. 2022;22.

Tušek-Bun K, Petek D. Comorbidities and characteristics of coronary heart disease patients: Their impact on health-related quality of life. Health Qual Life Outcomes. 2016;14.

Frøjd, L, Munkhaugen J, Papageorgiou C, Sverre E, Moum T, Dammen T. Predictors of health-related quality of life in outpatients with coronary heart disease. Front Psychol. 2023;14.

Muhammad I, He H, Thompson D, Kowitlawakul Y, Wang W. Health-related quality of life and its predictors among outpatients with coronary heart disease in Singapore. Applied Nursing Research. 2014;27;175–180.

Wang W, Jiang Y, Lee C. Independent predictors of physical health in community-dwelling patients with coronary heart disease in Singapore. Health Qual Life Outcomes. 2016;14.

Zhang Y, Yan F, Jiang W. Relationship between self-management behaviors and health-related quality of life among Chinese patients with coronary heart disease: A cross-sectional study. Contemp Nurse. 2019;55;554–564.

Dou L, Mao Z, Fu Q, Chen G, Li S. health-related quality of life and its influencing factors in patients with coronary heart disease in china. Patient Prefer Adheren. 2022;16;781–795.

Wang L, Wu Y, Tang X, Li N, He L, Cao Y, dkk. Profile and correlates of health-related quality of life in Chinese patients with coronary heart disease. Chin Med J. 2015;128;1853–1861.

Liang L, Liu Y, Shi Y, Jiang T, Zhang H, Liu B, dkk. Family care and subjective well-being of coronary heart disease patients after percutaneous coronary intervention: Mediating effects of coping strategies. Int J Nurs Sci. 2022;9;79–85.

Mei Y, Wu H, Zhang H, Hou J, Zhang Z, Liou W, dkk. Health-related quality of life and its related factors in coronary heart disease patients: results from the Henan Rural Cohort study. Sci Rep. 2021;11.

Lee D, Choi K, Chair S, Yu D, Lau S. Psychological distress mediates the effects of socio-demographic and clinical characteristics on the physical health component of health-related quality of life in patients with coronary heart disease. Eur J Prev Cardiol. 2014;21;107–116.

Dou L, Mao Z, Fu Q, Chen G, Li S. health-related quality of life and its influencing factors in patients with coronary heart disease in china. Patient Prefer Adherence. 2022;16;781–795.

Wang W, Lau Y, Chow A, Thompson D, He H. Health-related quality of life and social support among Chinese patients with coronary heart disease in mainland China. European Journal of Cardiovascular Nursing. 2014;13;48–54.

Tye SK, Kandavello G, Gan KL. Types of social supports predicting health-related quality of life among adult patients with CHD in the Institut Jantung Negara Malaysia. Cardiol Young. 2017;27;46–54.

Zhao S, Zhao H, Du S, Qin Y. The impact of clinical pharmacist support on patients receiving multi-drug therapy for coronary heart disease in china. Indian J Pharm Sci. 2015;77.

Published

2024-04-21

How to Cite

Lubna Farhana, Ramdini, D. A., Himayani, R., & Junando, M. (2024). Factors Affecting Health Related Quality Of Life (HRQoL) In Coronary Heart Disease Without Terminal Disease. Medical Profession Journal of Lampung, 14(4), 758-765. https://doi.org/10.53089/medula.v14i4.1045

Issue

Section

Artikel

Most read articles by the same author(s)

1 2 3 4 5 6 > >>